Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (2701)	10/21/2000 7:28:46 PM
From: DanZ	Respond to of 5582

Hot off the press from entjournal.com I don't think it is pure luck that the abstract on Zicam was placed at the very top of the articles. Also note that the p value in Dr. Hirt's study is highly significant (p < 0.05) and that the duration of symptoms resolved in 2.3 days in the Zicam group and 9.0 days in the placebo group. These are excellent results. Zinc nasal gel for the treatment of common cold symptoms: A double-blind, placebo-controlled trial Michael Hirt, MD Sion Nobel, MD Ernesto Barron, BS Abstract Effective treatments for the common cold have been difficult to develop because so many different types of virus are responsible for this condition. Oral zinc has been studied as a possible means of preventing or alleviating symptoms, with mixed results. We studied a new approach to zinc therapy—an over-the-counter nasal gel formulation (Zicam)—to independently evaluate its efficacy as a treatment for the common cold. Our study was conducted at four sites over a 5-month period. The study group consisted of 213 patients with recent-onset (24 hr) cold symptoms; 108 patients received zinc therapy, and 105 received placebo. Symptom charts were used to track the duration and severity of each patient's symptoms. At study's end, the duration of symptoms was 2.3 days (±0.9) in the zinc group and 9.0 days (±2.5) in the control group—a statistically significant difference (p<0.05). These results provide evidence that zinc nasal gel is effective in shortening the duration of common cold symptoms when taken within 24 hours of their onset.